Details of the Drug Formulations

General Information of Drug (ID: DM4O2Z7)

Drug Name
Cyclophosphamide Drug Info
Synonyms
ASTA; Ciclofosfamida; Ciclophosphamide; Clafen; Claphene; Cycloblastin; Cyclophosphamid; Cyclophosphamides; Cyclophosphamidum; Cyclophosphan; Cyclophosphane; Cyclophosphanum; Cyclophosphoramide; Cyclostin; Cyklofosfamid; Cytophosphan; Cytophosphane; Cytoxan; Endoxan; Endoxana; Endoxanal; Endoxane; Enduxan; Genoxal; Mitoxan; Neosar; Procytox; Revimmune; Semdoxan; Sendoxan; Senduxan; Zyklophosphamid; Ciclophosphamide [INN]; Cyclophosphamide Sterile; Cyclophosphamide anhydrous; Cyklofosfamid [Czech]; Cytoxan Lyoph; Endoxan R; Lyophilized Cytoxan; Zyklophosphamid [German]; ASTA B518; Asta B 518; B 518; C 0768; CB 4564; SK 20501; B-518; CB-4564; Ciclofosfamida [INN-Spanish]; Cyclophosphamide (INN); Cyclophosphamide (TN); Cyclophosphamide (anhydrous form); Cyclophosphamide (anhydrous); Cyclophosphamidum [INN-Latin]; Cytoxan (TN); Endoxan (TN); Endoxan-Asta; Neosar (TN); Occupation, cyclophosphamide exposure; Procytox (TN); Revimmune (TN); Bis(2-Chloroethyl)phosphami de cyclic propanolamide; Bis(2-Chloroethyl)phosphamide cyclic propanolamide ester; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; D,L-Cyclophosphamide; Cyclophosphamide, (+-)-Isomer; N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; (+-)-Cyclophosphamide; (-)-Cyclophosphamide; (RS)-Cyclophosphamide; 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine; 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin; 4-Hydroxy-cyclophosphan-mamophosphatide
Indication
Disease Entry ICD 11 Status REF
Advanced cancer 2A00-2F9Z Approved [1]
Central nervous system neoplasm Approved [1]
Glioblastoma 2A00 Approved [1]
Immunodeficiency 4A00-4A85 Approved [1]
Inflammatory breast cancer 2C62 Approved [1]
Lupus nephritis 4A40.0Y Approved [1]
Lymphoma 2A80-2A86 Approved [1]
Multiple sclerosis 8A40 Approved [1]
Mycosis fungoides 2B01 Approved [1]
Plasma cell myeloma 2A83.1 Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [2]
Classic Hodgkin lymphoma Investigative [1]
Neuroblastoma 2D11.2 Investigative [1]
Retinoblastoma 2D02.2 Investigative [1]
Scleroderma 4A42 Investigative [1]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
2907
ChEBI ID
CHEBI:4027
CAS Number
50-18-0
TTD ID
D0CT9C
VARIDT ID
DR00425
INTEDE ID
DR0391
ACDINA ID
D00157

Full List of Drug Formulations Containing This Drug

Cyclophosphamide 25 mg capsule
Company Formulation ID FDA Description
Avera McKennan Hospital F05155 Fd&c red no. 40; Sodium stearyl fumarate; Butyl alcohol; Fd&c blue no. 1; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac; Starch, corn
------------------------------------------------------------------------------------
Cyclophosphamide 50 mg capsule
Company Formulation ID FDA Description
Avera McKennan Hospital F05157 Fd&c red no. 40; Sodium stearyl fumarate; Butyl alcohol; Fd&c blue no. 1; Isopropyl alcohol; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin; Shellac; Starch, corn
------------------------------------------------------------------------------------
Cyclophosphamide 25 mg tablet
Company Formulation ID FDA Description
Physicians Total Care; Roxane Laboratories F05156 Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Acacia; Cellulose, microcrystalline
------------------------------------------------------------------------------------
Cyclophosphamide 50 mg tablet
Company Formulation ID FDA Description
Physicians Total Care; Roxane Laboratories F05158 Lactose monohydrate; Fd&c blue no. 1; Magnesium stearate; Acacia; Cellulose, microcrystalline
------------------------------------------------------------------------------------

References

1 Cyclophosphamide FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7154).